As of 4:00pm ET
| +11.07 / +2.20%|
The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 450.50, with a high estimate of 530.00 and a low estimate of 400.00. The median estimate represents a -12.22% decrease from the last price of 513.19.
The current consensus among 25 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.